xIPOmeter
Chai Discovery
Chai Discovery is a biotechnology company that uses artificial intelligence to design and engineer improved therapeutic molecules, particularly focusing on antibody development. Their platform, including their Chai-2 model, aims to create drug-like antibodies with atomic-level precision for difficult therapeutic targets.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to Chai Discovery11
Chai DiscoveryChai Discovery Announces Collaboration with Bristol Myers Squibb ...
Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery ...
https://ca.finance.yahoo.com/news/chai-discovery-announces-collaboration-bristol-130000984.htmlChai DiscoveryNovartis and Chai Discovery collaborate on antibody identification
Novartis and Chai Discovery collaborate on antibody identification ...
https://finance.yahoo.com/healthcare/articles/novartis-chai-discovery-collaborate-antibody-095747052.htmlChai DiscoveryChai Discovery, an A.I. Drug Start-Up, Raises $400 Million
From left, Matthew McPartlon, Joshua Meier, Jacques Boitreaud and Jack Dent stand in. The A.I. drug discovery start-up Chai Discovery was founded by, from left, ...
https://www.nytimes.com/2026/07/14/business/dealbook/chai-discovery-ai-drug-development.htmlChai DiscoveryChai Discovery nabs $400M Series C as AI-designed antibodies ...
Chai Discovery builds frontier AI models designed to accelerate drug discovery. They act by predicting and reprogramming molecular interactions, a necessary ...
https://siliconangle.com/2026/07/14/chai-discovery-nabs-400m-series-c-ai-designed-antibodies-reach-big-pharma/Chai DiscoveryChai Discovery Announces $400M Series C to Advance AI-Driven ...
Chai Discovery Announces $400M Series C to Advance AI-Driven Molecular Design ...
https://ca.finance.yahoo.com/news/chai-discovery-announces-400m-series-130000731.html
Show more (6)Investors8
OpenAI
General Catalyst
Thrive Capital
OpenAI
Menlo Ventures
General Catalyst
Index Ventures
Sequoia Capital